A Phase II trial of 5-drug oral antiangiogenic regimen in children with recurrent or progressive tumors
Session 1: Symposium On Pediatric Oncology
Speaker :
Dr. Mark Kieran, USA
A Phase II trial of 5-drug oral antiangiogenic regimen in children with recurrent or progressive tumors
Speaker :
Dr. Mark Kieran, USA